Wayne Markowitz - 07 May 2025 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role
GM & SVP, Surgical
Signature
Linda J. Park, Attorney-in-Fact
Issuer symbol
EW
Transactions as of
07 May 2025
Transactions value $
-$42,597
Form type
4
Filing time
09 May 2025, 19:34:16 UTC
Previous filing
06 Dec 2024
Next filing
15 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Markowitz Wayne GM & SVP, Surgical ONE EDWARDS WAY, IRVINE Linda J. Park, Attorney-in-Fact 09 May 2025 0001991414

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Sale -$20.1K -268 -2.8% $75.08 9.3K 07 May 2025 Direct
transaction EW Common Stock Tax liability -$22.5K -300 -3.23% $74.92 9K 07 May 2025 Direct
transaction EW Common Stock Award $0 +3.35K +37.23% $0.00 12.3K 08 May 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Employee Stock Option (Right to Acquire) Award $0 +17.1K $0.00 17.1K 08 May 2025 Common Stock 17.1K $74.63 Direct F2
transaction EW Performance Rights Award $0 +3.35K $0.00 3.35K 08 May 2025 Common Stock 3.35K Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
F2 These options were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
F3 Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 8, 2028. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This Form 4 includes quarterly acquisition of shares under the Issuer's Employee Stock Purchase Plan.